MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,623 Cr | ₹2,177 Cr | ₹1,852 Cr | ₹1,491 Cr | ₹1,376 Cr |
What is the latest Revenue of MARKSANS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,623 Cr |
| Mar2024 | ₹2,177 Cr |
| Mar2023 | ₹1,852 Cr |
| Mar2022 | ₹1,491 Cr |
| Mar2021 | ₹1,376 Cr |
How is Revenue of MARKSANS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,623 Cr | 20.46 | |
| Mar2024 | ₹2,177 Cr | 17.56 | |
| Mar2023 | ₹1,852 Cr | 24.23 | |
| Mar2022 | ₹1,491 Cr | 8.33 | |
| Mar2021 | ₹1,376 Cr | - | |
Compare Revenue of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,964.5 Cr | 0.3% | 8.9% | 8.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 0.3% |
8.9% |
8.1% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses